RCT | Doxycycline vs. placebo in patients with mild thyroid-associated ophthalmopathy.
30 Sep, 2022 | 12:35h | UTCDoxycycline vs Placebo at 12 Weeks in Patients With Mild Thyroid-Associated Ophthalmopathy: A Randomized Clinical Trial – JAMA Ophthalmology (free for a limited period)
Invited commentary: Oral Doxycycline for Mild Thyroid Eye Disease – JAMA Opthalmology (free for a limited period)